Prioritize protein at every meal, strength train 2 to 3 times a week covering all major muscle groups, and avoid losing more than 1 to 2 percent of your body weight per week
Sattele or his team of medical providers will recommend a schedule based on your goals
J Diabetes Metab Disord 24 , 253 (2025)
Incretin mimetics are ideal candidate therapies for T2D as they exert their actions specifically during hyperglycaemic conditions and have the additional capacity to regulate body weight ( Since 2005, six incretin therapy drugs have been approved by the FDA (United States) and the MHRA (United Kingdom) for T2D treatment: Exenatide, Lixisenatide, Liraglutide, Dulaglutide, Semaglutide and Tirzepatide, all of which are administered daily or once weekly via subcutaneous injection
Dose changes should not be made by guesswork, social media advice, or another patients experience
Improved Metabolism: Can enhance metabolic rates without impacting blood sugar levels